Quick Takeaways
- COLUMN GROUP II, LP filed SCHEDULE 13G/A for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC).
- Disclosed ownership: 3.7%.
- Date of event: 30 Sep 2025.
COLUMN GROUP II, LP - 30 Sep 2025 SCHEDULE 13G/A Report for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC)
- Filing Manager
- COLUMN GROUP II, LP
- Reporting Manager
- Peter Svennilson
- Symbol
- ORIC
- Shares outstanding
- 98,489,676 shares
- Disclosed Ownership
- 3,644,118 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Nov 2025, 20:17:05 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"COLUMN GROUP II, LP disclosed 3.7% ownership in ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Nov 2025, 20:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Column Group II, LP | 3.6% | 3,540,777 | 0 | 3,540,777 | /s/ James Evangelista, Attorney-in-Fact | James Evangelista, Attorney-in-Fact | |
| The Column Group II GP, LP | 3.6% | 3,540,777 | 0 | 3,540,777 | /s/ James Evangelista, Attorney-in-Fact | James Evangelista, Attorney-in-Fact | |
| David V Goeddel | 3.7% | 3,627,493 | 86,716 | 3,540,777 | /s/ James Evangelista, Attorney-in-Fact | James Evangelista, Attorney-in-Fact | |
| Peter Svennilson | 3.7% | 3,644,118 | 103,341 | 3,540,777 | /s/ James Evangelista, Attorney-in-Fact | James Evangelista, Attorney-in-Fact |